SENSEX
NIFTY
GOLD
USD/INR

Weather

image 35    C

Company News

The Economic Times

Company / The Economic Times

details

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

A US judge has dismissed Bayer's plea to halt Johnson & Johnson's advertising for its prostate cancer drug Erleada. Bayer alleged false claims about a halved death risk compared to its own drug, Nubeqa. The court found J&J's campaign accurately reflected its study's findings, deeming Bayer's arguments insufficient for an injunction. Bayer vows to pursue the case on its merits.

18 Apr 2026 7:54 am